Sulggi Angela Lee BA, MD, PhD

Dr. Lee After graduating from Stanford University, Dr. Lee went on to receive an MD/PhD at the University of Southern California. She has lived in the Bay Area since the third grade though she was born in Naperville, IL, and spent a few years in Sandy, UT. She returned to Stanford for her internal medicine training, followed by an Infectious Disease fellowship at UCSF.
Her impressive training has launched a quickly accelerating career. Her most recent findings set the stage for her next steps, identifying therapeutic approaches to HIV eradication that would combine practical clinical approaches (early HIV treatment) with novel therapeutic target discovery (e.g., host-HIV genetic omics approaches) to potentially apply towards future HIV eradication strategies.
Lee is now working to merge the two studies presented at this conference: 1) a phase IV trial providing immediate antiretroviral therapy to new, acute HIV-infected individuals and following them over time; and 2) a study that will determine whether timing of ART initiation influences where and how frequently HIV integrates into the host genome, potentially influence HIV latency.